SE0203526D0 - New use of dextran sulfate - Google Patents
New use of dextran sulfateInfo
- Publication number
- SE0203526D0 SE0203526D0 SE0203526A SE0203526A SE0203526D0 SE 0203526 D0 SE0203526 D0 SE 0203526D0 SE 0203526 A SE0203526 A SE 0203526A SE 0203526 A SE0203526 A SE 0203526A SE 0203526 D0 SE0203526 D0 SE 0203526D0
- Authority
- SE
- Sweden
- Prior art keywords
- dextran sulfate
- new use
- human patient
- cell transplant
- therapeutic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
- A61K31/721—Dextrans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/37—Digestive system
- A61K35/39—Pancreas; Islets of Langerhans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
- A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
- A61L27/3839—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by the site of application in the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/54—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/23—Carbohydrates
- A61L2300/232—Monosaccharides, disaccharides, polysaccharides, lipopolysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/41—Anti-inflammatory agents, e.g. NSAIDs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/45—Mixtures of two or more drugs, e.g. synergistic mixtures
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
- A61L2300/64—Animal cells
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dermatology (AREA)
- Immunology (AREA)
- Cell Biology (AREA)
- Transplantation (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Botany (AREA)
- Virology (AREA)
- Gastroenterology & Hepatology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Biotechnology (AREA)
- Developmental Biology & Embryology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Saccharide Compounds (AREA)
Priority Applications (31)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0203526A SE525461C3 (sv) | 2002-11-28 | 2002-11-28 | Ny användning av dextransulfat |
PT03811973T PT1567171E (pt) | 2002-11-28 | 2003-11-26 | Utilização de sulfato de dextrano para o tratamento de reacção inflamatória instantânea veiculada pelo sangue (riivs). |
KR1020057009717A KR100828807B1 (ko) | 2002-11-28 | 2003-11-26 | 새로운 용도의 덱스트란 설페이트 |
AT03811973T ATE359798T1 (de) | 2002-11-28 | 2003-11-26 | Verwendungvon dextransulfat zur behandlung von ibmir |
CNB2003801045438A CN1296051C (zh) | 2002-11-28 | 2003-11-26 | 糖酐酯的新用途 |
NZ540744A NZ540744A (en) | 2002-11-28 | 2003-11-26 | Dextran sulphate used to treat Instant Blood-Mediated Inflammatory Reaction (IBMIR) |
CA2507595A CA2507595C (en) | 2002-11-28 | 2003-11-26 | Use of dextran sulfate in the treatment of instant blood-mediated inflammatory reaction |
DK03811973T DK1567171T3 (da) | 2002-11-28 | 2003-11-26 | Anvendelse af dextransulfat til behandling af ibmir |
SI200330809T SI1567171T1 (sl) | 2002-11-28 | 2003-11-26 | Uporaba dekstran sulfata za zdravljenje IBMIR |
BRPI0316666A BRPI0316666B8 (pt) | 2002-11-28 | 2003-11-26 | novo uso de sulfato de dextrano |
EP03811973A EP1567171B1 (en) | 2002-11-28 | 2003-11-26 | Use of dextran sulfate for treating ibmir |
PL376302A PL216067B1 (pl) | 2002-11-28 | 2003-11-26 | Zastosowanie siarczanu dekstranu |
ES03811973T ES2285270T3 (es) | 2002-11-28 | 2003-11-26 | Uso de sulfato de dextrano para tratar ibmir. |
AU2003302378A AU2003302378B2 (en) | 2002-11-28 | 2003-11-26 | New use of dextran sulfate |
JP2004555208A JP4315908B2 (ja) | 2002-11-28 | 2003-11-26 | デキストラン硫酸エステルの新規用途 |
PCT/SE2003/001830 WO2004047848A1 (en) | 2002-11-28 | 2003-11-26 | New use of dextran sulfate |
DE60313356T DE60313356T2 (de) | 2002-11-28 | 2003-11-26 | Verwendungvon dextransulfat zur behandlung von ibmir |
US10/535,876 US8629123B2 (en) | 2002-11-28 | 2003-11-26 | Use of dextran sulfate |
EA200500757A EA010409B1 (ru) | 2002-11-28 | 2003-11-26 | Применение декстрансульфата для ингибирования немедленной воспалительной реакции, опосредованной кровью |
HR20050439A HRP20050439B1 (en) | 2002-11-28 | 2005-05-17 | New use of dextran sulfate |
IL168626A IL168626A (en) | 2002-11-28 | 2005-05-17 | Use of dextran sulfate for the preparation of drugs for the treatment of IBMIR |
ZA200504111A ZA200504111B (en) | 2002-11-28 | 2005-05-20 | New use of dexytran sulfate |
NO20052505A NO326946B1 (no) | 2002-11-28 | 2005-05-25 | Anvendelse av dekstransulfat for behandling av IBMIR |
IS7908A IS2405B (is) | 2002-11-28 | 2005-06-23 | Notkun dextransúlfats til að meðhöndla skyndilegtblóðmiðlað bólguviðbragð (IBMIR) |
HK06107463A HK1087042A1 (en) | 2002-11-28 | 2006-07-03 | New use of dextran sulfate |
CY20071100954T CY1106739T1 (el) | 2002-11-28 | 2007-07-17 | Χρηση του dextran sulfate (δεξτρανη θειικου αλατος) για θεραπεια της αμεσης αιμοκινουμενης φλεγμονωδους αντιδρασης |
JP2009064780A JP4972113B2 (ja) | 2002-11-28 | 2009-03-17 | デキストラン硫酸エステルを含有する新規治療薬 |
US12/685,005 US8906884B2 (en) | 2002-11-28 | 2010-01-11 | Method of treating graft-rejection using dextran sulfate |
US14/099,493 US9364499B2 (en) | 2002-11-28 | 2013-12-06 | Use of dextran sulfate |
US14/099,518 US8901104B2 (en) | 2002-11-28 | 2013-12-06 | Use of dextran sulfate |
US15/001,380 US10307440B2 (en) | 2002-11-28 | 2016-01-20 | Use of dextran sulfate |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0203526A SE525461C3 (sv) | 2002-11-28 | 2002-11-28 | Ny användning av dextransulfat |
Publications (4)
Publication Number | Publication Date |
---|---|
SE0203526D0 true SE0203526D0 (sv) | 2002-11-28 |
SE0203526L SE0203526L (sv) | 2004-05-29 |
SE525461C2 SE525461C2 (sv) | 2005-02-22 |
SE525461C3 SE525461C3 (sv) | 2005-03-23 |
Family
ID=20289705
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE0203526A SE525461C3 (sv) | 2002-11-28 | 2002-11-28 | Ny användning av dextransulfat |
Country Status (26)
Country | Link |
---|---|
US (5) | US8629123B2 (sv) |
EP (1) | EP1567171B1 (sv) |
JP (2) | JP4315908B2 (sv) |
KR (1) | KR100828807B1 (sv) |
CN (1) | CN1296051C (sv) |
AT (1) | ATE359798T1 (sv) |
AU (1) | AU2003302378B2 (sv) |
BR (1) | BRPI0316666B8 (sv) |
CA (1) | CA2507595C (sv) |
CY (1) | CY1106739T1 (sv) |
DE (1) | DE60313356T2 (sv) |
DK (1) | DK1567171T3 (sv) |
EA (1) | EA010409B1 (sv) |
ES (1) | ES2285270T3 (sv) |
HK (1) | HK1087042A1 (sv) |
HR (1) | HRP20050439B1 (sv) |
IL (1) | IL168626A (sv) |
IS (1) | IS2405B (sv) |
NO (1) | NO326946B1 (sv) |
NZ (1) | NZ540744A (sv) |
PL (1) | PL216067B1 (sv) |
PT (1) | PT1567171E (sv) |
SE (1) | SE525461C3 (sv) |
SI (1) | SI1567171T1 (sv) |
WO (1) | WO2004047848A1 (sv) |
ZA (1) | ZA200504111B (sv) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2007312880A1 (en) * | 2006-10-20 | 2008-04-24 | The Australian National University | Inhibition of degradation of extracellular matrix |
US20110008343A1 (en) * | 2007-06-08 | 2011-01-13 | Lambris John D | Method Of Reducing Tissue Loss In Pancreatic Islet Cell Transplantation |
US20130143840A1 (en) * | 2010-03-12 | 2013-06-06 | Christopher Richard Parish | Heparan sulfate replacement therapy |
EP2593113B1 (en) * | 2010-07-16 | 2019-04-24 | TX Medic AB | Cell therapy |
CN102973592A (zh) * | 2012-11-26 | 2013-03-20 | 合肥博太医药生物技术发展有限公司 | 硫酸葡聚糖在制备治疗糖尿病药物中的应用 |
SE537742C2 (sv) * | 2013-05-13 | 2015-10-13 | Tx Medic Ab | Dextransulfat för cellmobilisering |
GB201408233D0 (en) | 2014-05-09 | 2014-06-25 | Austrianova Singapore Pte Ltd | Use of polyanionic composition |
DK3154551T3 (en) * | 2014-06-12 | 2019-01-28 | Tx Medic Ab | APPLICATION OF DEXTRANSULPHATE WITH A MEDIUM MOLECULAR WEIGHT UNDER 10,000 EN TO INJECT ANGIOGENES OF AN INDIVIDUAL |
WO2015190989A1 (en) * | 2014-06-12 | 2015-12-17 | Tx Medic Ab | The use of dextran sulfate having an average molecular weight below 10000 da for inducing angiogenisis in a subject |
SE538503C2 (sv) | 2014-11-11 | 2016-08-16 | Tx Medic Ab | New dextran sulfate |
SE539575C2 (sv) * | 2015-07-30 | 2017-10-17 | Tx Medic Ab | Dextran sulfate for use in treating, inhibiting or preventing cardiac fibrosis |
CA3074987A1 (en) * | 2017-09-08 | 2019-03-14 | Tx Medic Ab | New use of dextran sulfate |
EP4135720A4 (en) * | 2020-04-15 | 2024-04-17 | TX Medic AB | TREATMENT OF SEPSIS AND HYPERCYTOKINEMIA |
SE544768C2 (en) * | 2021-03-24 | 2022-11-08 | Tx Medic Ab | Combination for treatment of thromboinflammation |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0240098A3 (en) * | 1986-04-04 | 1989-05-10 | Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo | Oligo and polysaccharides for the treatment of diseases caused by retroviruses |
IL88554A0 (en) * | 1988-12-01 | 1989-07-31 | Hadassah Med Org | Compositions containing a compound binding to a heparin receptor |
TW318142B (sv) | 1991-06-03 | 1997-10-21 | Mitsubishi Chemicals Co Ltd | |
US5464815A (en) | 1993-09-08 | 1995-11-07 | Genentech, Inc. | Inhibition of heparin-binding |
CN1178070A (zh) * | 1996-09-27 | 1998-04-08 | 刘春江 | 组织脏器移植用保存溶液·手术等时组织脏器保护溶液 |
CN1057192C (zh) * | 1997-09-10 | 2000-10-11 | 上海长征医院 | 一种配制多器官保存液的方法 |
-
2002
- 2002-11-28 SE SE0203526A patent/SE525461C3/sv not_active IP Right Cessation
-
2003
- 2003-11-26 DE DE60313356T patent/DE60313356T2/de not_active Expired - Lifetime
- 2003-11-26 CA CA2507595A patent/CA2507595C/en not_active Expired - Lifetime
- 2003-11-26 PT PT03811973T patent/PT1567171E/pt unknown
- 2003-11-26 NZ NZ540744A patent/NZ540744A/en not_active IP Right Cessation
- 2003-11-26 PL PL376302A patent/PL216067B1/pl unknown
- 2003-11-26 ES ES03811973T patent/ES2285270T3/es not_active Expired - Lifetime
- 2003-11-26 AT AT03811973T patent/ATE359798T1/de active
- 2003-11-26 WO PCT/SE2003/001830 patent/WO2004047848A1/en active IP Right Grant
- 2003-11-26 CN CNB2003801045438A patent/CN1296051C/zh not_active Expired - Lifetime
- 2003-11-26 KR KR1020057009717A patent/KR100828807B1/ko active IP Right Grant
- 2003-11-26 AU AU2003302378A patent/AU2003302378B2/en not_active Expired
- 2003-11-26 EP EP03811973A patent/EP1567171B1/en not_active Expired - Lifetime
- 2003-11-26 DK DK03811973T patent/DK1567171T3/da active
- 2003-11-26 EA EA200500757A patent/EA010409B1/ru not_active IP Right Cessation
- 2003-11-26 BR BRPI0316666A patent/BRPI0316666B8/pt active IP Right Grant
- 2003-11-26 SI SI200330809T patent/SI1567171T1/sl unknown
- 2003-11-26 JP JP2004555208A patent/JP4315908B2/ja not_active Expired - Lifetime
- 2003-11-26 US US10/535,876 patent/US8629123B2/en active Active
-
2005
- 2005-05-17 HR HR20050439A patent/HRP20050439B1/xx not_active IP Right Cessation
- 2005-05-17 IL IL168626A patent/IL168626A/en active IP Right Grant
- 2005-05-20 ZA ZA200504111A patent/ZA200504111B/en unknown
- 2005-05-25 NO NO20052505A patent/NO326946B1/no not_active IP Right Cessation
- 2005-06-23 IS IS7908A patent/IS2405B/is unknown
-
2006
- 2006-07-03 HK HK06107463A patent/HK1087042A1/xx not_active IP Right Cessation
-
2007
- 2007-07-17 CY CY20071100954T patent/CY1106739T1/el unknown
-
2009
- 2009-03-17 JP JP2009064780A patent/JP4972113B2/ja not_active Expired - Lifetime
-
2010
- 2010-01-11 US US12/685,005 patent/US8906884B2/en active Active
-
2013
- 2013-12-06 US US14/099,493 patent/US9364499B2/en not_active Expired - Fee Related
- 2013-12-06 US US14/099,518 patent/US8901104B2/en not_active Expired - Lifetime
-
2016
- 2016-01-20 US US15/001,380 patent/US10307440B2/en not_active Expired - Lifetime
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20052505L (no) | Ny bruk av dextran-sulfat | |
CY1107850T1 (el) | Παραγωγα θειαδιαζολυλοπιπεραζiνης mε χρησιμοτητα στην αποτροπη ή στην αγωγη εναντι tου αλγους | |
NO20065904L (no) | Terapeutiske forbindelser | |
EP2277992A3 (en) | Progenitor cells from Wharton's jelly of human umbilical cord | |
BR0203650A (pt) | Estentor de auto-articulação | |
NO20043871L (no) | Legemiddelformuleringer med kontrollert frigjoring som inneholder et baererpeptid | |
WO2004076631A3 (en) | Biologically active native biomatrix composition | |
ATE495187T1 (de) | Dalda-analoge und ihre verwendung | |
WO2002002593A3 (en) | Modulators of cellular proliferation and angiogenesis, methods for use and identification thereof | |
AU2002239830A1 (en) | Pyruvate cardioplegia solutions for administration to the heart during cardiopulmonary surgery and methods of use thereof | |
DK0998287T3 (da) | Anvendelse af levobupivacain | |
NZ507203A (en) | Use of dexmedetomidine for ICU sedation | |
ATE489963T1 (de) | Chaperonin-10-immunosuppression | |
BR0312365A (pt) | Meio de cultura autólogo de células-mães progenitoras autólogas humanas, métodos para a preparação do mesmo e de uma composição de células-mães progenitoras autólogas humanas e para a obtenção de células-mães progenitoras musculares autólogas humanas, emprego de um meio de cultura autólogo de células-mães progenitoras autólogas humanas, procedimento para a obtenção de células-mães progenitoras musculares autólogas humanas e procedimento terapêutico de cardiomioplastia celular autóloga, composição enriquecida com células-mães progenitoras musculares autólogas humanas e composição farmacêutica | |
EP2072082A3 (en) | N-(3-methoxy-5-methylpyrazin-2-yl)-2-(4-[1,3,4-oxadiazol-2-yl]phenyl)pyridine-3 sulfonamide as analgetic agent | |
RS51420B (en) | HYPERSTRUCTURE AMYLOPECTIN FOR USE IN THE PROCEDURES OF SURGICAL OR THERAPEUTIC TREATMENT OF mammals OR IN THE PROCEDURES OF DIAGNOSIS, AND PARTICULARLY FOR USE AS A PLASMA VOLUME EXPANDER | |
MXPA02005069A (es) | Agentes de enlace especificos para t3 y metodos para su uso. | |
HUP0203486A2 (hu) | Véralvadással összefüggő betegségek megelőzése és kezelése | |
ECSP045210A (es) | 2' - halo - 3' , 5' - dialcoxi - fen - 1' - il - imino - 2 -imidazolidinas y su uso como un fármaco | |
BRPI0407304A (pt) | Agentes antibacterianos | |
DE60209355D1 (de) | Kosmetische zubereitung gegen hautfalten | |
DE60130253D1 (de) | Zusammensetzungen zur verhinderung der adhäsion | |
PT1067907E (pt) | Solucao para irrigacao ocular | |
RU99111148A (ru) | Глазные капли | |
ITTO20030126A1 (it) | Composizione di integratore alimentare atta a favorire l'assorbimento del ferro. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
NUG | Patent has lapsed |